PapersPMID:18611150
Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial.
What moved
1 findingHow to read these marks →“Controlling for baseline cognitive deficit using the Blessed Orientation-Memory-Concentration test, Bacopa participants had enhanced AVLT delayed word recall memory scores relative to placebo.”
- Study
- RCT
- Duration
- 3 months
- Dose studied
- 300 mg/day
- Population
- Healthy elderly participants aged 65 or older (mean age 73.5 years), without clinical signs of dementia
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- Community-dwelling adults aged 65 or older (mean age 73.5 years) without clinical signs of dementia, recruited in Portland, Oregon
- Participants
- 54
- Comparator
- placebo
- Duration
- 84 days
- Endpoints measured
- 10